Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Avidity Partners Management LP reported a 9.90% stake in Dianthus Therapeutics, Inc. (Schedule 13D/A)
Event Mar 17, 2025 · Filed Mar 19, 2025
Avidity Partners Management LP reported a 9.90% stake in Dianthus Therapeutics, Inc., 3,378,939 shares, with active intent on Mar 17, 2025. Filed Mar 19, 2025 (Schedule 13D/A).
- Stake
- 9.90%
- Shares
- 3,378,939
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avidity Partners Management LP | 9.90% | 3,378,939 |
| Avidity Partners Management (GP) LLC | 9.90% | 3,378,939 |
| Avidity Capital Partners Fund (GP) LP | 9.90% | 3,378,939 |
| Avidity Capital Partners (GP) LLC | 9.90% | 3,378,939 |
| Avidity Master Fund LP | 2.30% | 764,610 |
| Avidity Private Master Fund I LP | 8.30% | 2,749,625 |
| Michael Gregory | 9.90% | 3,378,939 |
Source
Related
- Dianthus Therapeutics, Inc.
- Avidity Partners Management LP
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13D/A · Avidity Partners Management LP · Nov 19, 2025
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026